Almost half of the staff at Lexicon Pharmaceuticals are to lose their jobs, an announcement that was made by chief executive Arthur Sands at the same time as he said he would step down from his ...
Lexicon Pharmaceuticals is reorganizing to cut costs and increase the efficiency of its R&D operations. It will reduce staff by about 100 people, or 20% of its workforce, at its headquarters in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results